Viewing Study NCT05194735

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:04 PM
Ignite Modification Date: 2026-05-17 @ 1:47 PM
Study NCT ID: NCT05194735
Status: TERMINATED
Last Update Posted: 2025-11-07
First Post: 2021-12-06
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Phase I/II Study of Autologous T Cells to Express T-Cell Receptors (TCRs) in Subjects With Solid Tumors
Sponsor: Alaunos Therapeutics
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Gynecologic Cancer View
None Colorectal Cancer View
None Pancreatic Cancer View
None Non-small Cell Lung Cancer View
None Cholangiocarcinoma View
None Ovarian Cancer View
None Endometrial Cancer View
None Ovarian Carcinoma View
None Ovary Neoplasm View
None Squamous Cell Lung Cancer View
None Adenocarcinoma of Lung View
None Adenosquamous Cell Lung Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None adoptive cell therapy View
None neoantigen View
None T cell receptor View
None T lymphocyte View
None TCR-engineered T cells View
None cell therapy View
None immunotherapy View
None IL-2 View
None Gene therapy View